Influence of sodium butyrate on hepatocellular carcinoma (HepG2) and glioblastoma (C6) cell lines in vitro

Acta Poloniae Pharmaceutica - Drug Research

Volumn 64, Issue 6, 2007, Pages 561-563

  Joachimiak, Romana ^a   Kaźnica, Anna ^a   Drewa, Tomasz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cytotoxicity in vitro; Glioblastoma; Liver cancer; Sodium butyrate

Indexed keywords

ANTIBIOTIC AGENT; BUTYRIC ACID;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CULTURE MEDIUM; DRUG EFFECT; DRUG SENSITIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; BUTYRATES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GLIOBLASTOMA; HUMANS; INHIBITORY CONCENTRATION 50; TIME FACTORS;

EID: 40549111956     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Velazquez O., Jabbar A., DeMatteo R., Rombean J.: Surgery 120, 2 (1996).
2. Tabuchi Y., Arai Y., Kondo T., Takeguchi N., Asano S.: Biochem. Biophys. Res. Commun. 293, 1287 (2002).
3. Jeng J., Ping Kuo M., Lee P., Wang Y., Lee M., Lee J., Lin B.: Toxicology 223, 235 (2006).
4. Ogawa K., Yasumura S., Atarashi Y., et al.: J. Hepatol. 40, 278 (2004).
5. Emanuele S., Anneo A.D., Bellavia G., et al.: Eur. J. Cancer 40, 1441 (2004).
6. Karasawa Y., Okisaka S.: Jpn. J. Ophthalmol. 48, 542 (2004).
7. Daehn I., Varelas A., Rayner T.: Apoptosis 11, 1379 (2006).
8. Hirsch C. L., Bonham K.: FEBS Lett. 570, 37 (2004).
9. Henderson C., Brancolini C.: Drug Resist. Updat. 6, 247 (2003).
10. Pouillart P.: Life Sci. 63, 20 (1998).
11. Olszewska-Slonina D., Drewa T., Musialkiewicz D., Olszewski K.: Acta Pol. Pharm. 61, 31 (2004).
12. Amano H., Kurosaka R., Ema M., Ogawa Y.: Neurosci. Res. 25, 203 (1996).
13. Scheppach W., Bartram H.P., Richter F.: Eur. J. Cancer 31A, 1077 (1995).
14. Gibson P. R., Moeller I., Kagelari O., Folino M., Young G. P.: J. Gastroenterol. Hepatol. 7, 165 (1992).
15. Sung Y. H., Song Y. J., Lim S. W., Chung J. Y., Lee G. M.: J. Biotechnol. 112, 323 (2004).
16. Marks P. A., Rifkind R. A., Richon V. M., Breslow R., Miller T., Kelly W. K.: Nat. Rev. Cancer 1, 194 (2001).